NEWRON PHARMACEUT. EO-,20/ IT0004147952 /
12/10/2024 09:15:29 | Chg. 0.000 | Volume | Bid09:15:29 | Ask09:15:29 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
7.810EUR | 0.00% | - Turnover: - |
7.810Bid Size: - | 7.920Ask Size: - | 140.24 mill.EUR | - | - |
Assets
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | .1000 | .1000 | .1000 | .1000 | .1000 | ||||||
Intangible Assets | .3000 | .3000 | 0.0000 | 0.0000 | .0200 | ||||||
Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Fixed Assets | .4000 | .5000 | .2000 | .2000 | .3000 | ||||||
Inventories | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Accounts Receivable | - | - | - | - | - | ||||||
Cash and Cash Equivalents | 36 | 42.9000 | 56.3000 | 27.6000 | 22.1000 | ||||||
Current Assets | 44 | 56.1000 | 72.8000 | 59.5000 | 59.9000 | ||||||
Total Assets | 44.4000 | 56.6000 | 73 | 59.7000 | 60.3000 |
Liabilities
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 6.2000 | 6.3000 | 4.7000 | 4.3000 | 5.5000 | ||||||
Long-term debt | .4000 | - | - | - | 16.7000 | ||||||
Liabilities to Banks | .8000 | .4000 | 0.0000 | 0.0000 | 16.7000 | ||||||
Provisions | .1000 | .1000 | - | - | - | ||||||
Liabilities | 7.3000 | 6.8000 | 5.3000 | 4.9000 | 23.5000 | ||||||
Share Capital | 2.8000 | 3.2000 | 3.6000 | 3.6000 | 3.6000 | ||||||
Total Equity | 37.1000 | 49.7000 | 67.7000 | 54.8000 | 36.8000 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 44.4000 | 56.6000 | 73 | 59.7000 | 60.3000 |
Income Statement
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2.4000 | 6.7000 | 13.4000 | 4 | 7 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | -24.4000 | -15.3000 | -4.3000 | -15 | -20.9000 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | -25 | -15.2000 | -5.3000 | -15 | -20.2000 | ||||||
Income Taxes | 2.2000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Net Income | -22.8000 | -15.2000 | -5.3000 | -15 | -20.2000 |
Per Share
Cash Flow
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -12.9000 | -19.6000 | -8.4000 | -16.1000 | -22.2000 | ||||||
Cash Flow from Investing Activities | 2.1000 | 1.4000 | -.2000 | 3 | -.9000 | ||||||
Cash Flow from Financing | 28 | 25.1000 | 22 | .1000 | 17.6000 | ||||||
Decrease / Increase in Cash | 17.3000 | 6.9000 | 13.3000 | -13 | -5.6000 | ||||||
Employees | 23 | 23 | 23 | 24 | 26 |